Cellcom Israel Stock Gross Profit
Cellcom Israel fundamentals help investors to digest information that contributes to Cellcom Israel's financial success or failures. It also enables traders to predict the movement of Cellcom Stock. The fundamental analysis module provides a way to measure Cellcom Israel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellcom Israel stock.
Cellcom |
Cellcom Israel Company Gross Profit Analysis
Cellcom Israel's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Cellcom Israel Gross Profit | 983 M |
Most of Cellcom Israel's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellcom Israel is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Cellcom Israel reported 983 M of gross profit. This is 98.74% lower than that of the Communication Services sector and 99.83% lower than that of the Telecom Services industry. The gross profit for all United States stocks is 96.41% higher than that of the company.
Cellcom Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellcom Israel's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellcom Israel could also be used in its relative valuation, which is a method of valuing Cellcom Israel by comparing valuation metrics of similar companies.Cellcom Israel is currently under evaluation in gross profit category among its peers.
Cellcom Fundamentals
Return On Equity | -10.15 | |||
Return On Asset | -0.17 | |||
Profit Margin | (4.98) % | |||
Current Valuation | 613.79 M | |||
Shares Outstanding | 162.78 M | |||
Shares Owned By Insiders | 47.60 % | |||
Shares Owned By Institutions | 17.74 % | |||
Number Of Shares Shorted | 40.51 K | |||
Price To Earning | 223.44 X | |||
Price To Book | 0.94 X | |||
Price To Sales | 0.57 X | |||
Revenue | 1.03 B | |||
Gross Profit | 983 M | |||
EBITDA | 171.31 M | |||
Net Income | (4.94 M) | |||
Cash And Equivalents | 326.7 M | |||
Cash Per Share | 2.89 X | |||
Total Debt | 956.5 M | |||
Debt To Equity | 1.92 % | |||
Current Ratio | 1.09 X | |||
Book Value Per Share | 4.01 X | |||
Cash Flow From Operations | 224.3 M | |||
Short Ratio | 3.16 X | |||
Earnings Per Share | (0.05) X | |||
Price To Earnings To Growth | 11.99 X | |||
Number Of Employees | 3.27 K | |||
Beta | 0.71 | |||
Market Capitalization | 608.42 M | |||
Total Asset | 6.28 B | |||
Retained Earnings | 1.16 B | |||
Working Capital | 625 M | |||
Current Asset | 2.48 B | |||
Current Liabilities | 1.86 B | |||
Last Dividend Paid | 0.24 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Cellcom Stock
If you are still planning to invest in Cellcom Israel check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellcom Israel's history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bonds Directory Find actively traded corporate debentures issued by US companies |